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Summary
Purpose To describe the management of a serious ad-
verse event in a patient undergoing penetrating ker-
atoplasty (PK).
Case report A 68-year-old man underwent PK for an
aphakic bullous keratopathy following previous com-
plicated cataract surgery. He had no past history of
herpetic disease. Storage of the corneoscleral disc in
the transport bottle precluded microscopic examina-
tion. After placement of the trephined donor cornea
on the open eye of the recipient, a large dendritiform
geographic ulcer was noted on the donor cornea.
A replacement cornea was used after changing po-
tentially contaminated instruments. Intravenous an-
tiviral treatment was commenced intraoperatively to
reduce the risk of infection to the central nervous
system. Postoperatively, oral and topical antiviral
treatment was commenced and 6 months following
surgery the patient developed a geographic corneal
ulcer at the graft host interface.
Conclusion Containers to transport corneoscleral
discs should enable microscopic examination by the
surgeon prior to use. High dose systemic antivirals
may reduce the risk of herpetic disease involving the
posterior segment of the eye and neuroretina in the
aphakic eye and spread to the central nervous system.
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Schweres unerwünschtes Operationsereignis:
Management einer vermuteten HSV-1-Keratitis in
einer Spenderhornhaut
Zusammenfassung
Zweck Beschreibung des Managements eines uner-
wünschten Ereignisses bei einem Patienten, der eine
penetrierende Keratoplastik (PK) erhielt.
Fallbericht Ein 68-jähriger männlicher Patient unter-
zog sich einer PK aufgrund einer aphaken bullösen
Keropathie nach einer früheren komplizierten Ka-
taraktoperation. Er hatte keine Vorgeschichte einer
Herpeserkrankung. Aufgrund der Aufbewahrung der
korneoskleralen Scheibe in der Transportflasche war
eine mikroskopische Untersuchung nicht möglich.
Nach dem Einbringen der präparierten Spenderhorn-
haut in das offene Auge des Empfängers wurde ein
großes dendritisches (geographisches) Ulkus auf der
Spenderhornhaut festgestellt. Es wurde eine Ersatz-
hornhaut verwendet, nachdem die potenziell konta-
minierten Instrumente ausgetauscht worden waren.
Intraoperativ wurde eine intravenöse antivirale Be-
handlung begonnen, um das Risiko einer Infektion
des Zentralnervensystems zu reduzieren. Postoperativ
wurde mit der oralen und topischen antiviralen The-
rapie begonnen. Sechs Monate nach der Operation
entwickelte der Patient ein geographisches Horn-
hautulkus an der Grenzfläche von Transplantat und
Wirtsgewebe.
Schlussfolgerung Behältnisse zum Transport von kor-
neoskleralen Scheiben sollten vor deren Verwendung
eine mikroskopische Untersuchung durch den Ope-
rateur erlauben. Hoch dosierte systemische antivirale
Medikamente könnten das Risiko einer herpetischen
Erkrankung reduzieren, die das hintere Augensegment
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sowie die Neuroretina im phakischen Auge betreffen
und eine Ausbreitung auf das Zentralnervensystem
nach sich ziehen kann.
Schlüsselwörter Herpes Simplex (HSV) · Keratitis ·
Spender · Empfänger · Hornhauttransplantation
Introduction
Herpes simplex keratitis (HSK) is one of the major
causes of corneal inflammation and corneal blind-
ness, rated just second to trauma in most developed
countries [1–3]. Clinical reports support the possi-
ble transmission of herpes simplex virus type 1 (HSV-
1) via donor corneas and its role in graft failure [4].
Cleator et al. reported a case of primary graft fail-
ure due to presumed donor-to-host transmission of
HSV following organ culture in a patient who under-
went a penetrating keratoplasty for keratoconus [5].
It has also been reported that the HSV-1 may remain
viable in stored corneal tissue at 4° [6]. There are re-
ports of post-keratoplasty HSV-1 infection in patients
with no history of an herpetic infection [7, 8] and ev-
idence of donor-to-host transmission of the virus has
also been demonstrated in animal studies. In rab-
bits, latently infected donor tissue can induce HSV-1
infection in naive recipients after penetrating kerato-
plasty [9]. HSV-1 inoculation in the anterior chamber
of one eye has been shown to lead to the spread of
virus to the brain, contralateral optic nerve and then
posterior segment of contralateral eye [10, 11]. We re-
port a case of clinically suspected HSK in the donor
cornea following organ culture and subsequently in
the recipient following penetrating keratoplasty and
the perioperative management to reduce the infec-
tion risk and development of disease of the central
nervous system.
Case report
A 68-year-old man underwent penetrating kerato-
plasty for aphakic bullous keratopathy and corneal
Fig. 1 Dendritic-geographic epithelial ulcer on thedonor tis-
sue
scarring. He had no history of herpetic disease. The
donor cornea originated from a 71-year-old female
who died due to chronic pulmonary disease. The
time interval between death and transfer of the cor-
neoscleral button into organ culture medium was
36 h. The endothelial count was 2400cell/mm2 with
mild polymegethism and pleomorphism. A 8.5mm
Hessberg–Barron trephine was used to prepare the
donor cornea and a 8mm trephine for the recipi-
ent. After placement of the donor onto the aphakic
eye a large dendritic-geographic epithelial ulcer was
noted (Fig. 1). The graft was removed, all surgical
instruments were changed and the surgical staff re-
gowned. Fortunately, a second donor corneoscleral
disc was available, which was then used to complete
the operation instead of resuturing the patient’s own
cornea back into place. The second donor originated
from a 69-year-old male who died from a myocar-
dial infarction. The time interval between death and
transfer of the corneoscleral button into organ cul-
ture medium was 40 h. The endothelial count was
2600cell/mm2 with some variation in cell size and
shape.
Perioperative intravenous aciclovir was adminis-
tered intravenously (5mg/kg). Postoperatively, the
patient was commenced on systemic and local an-
tiviral therapy for 1 week (valaciclovir 1 g three times
a day, acyclovir ointment five times per day) and lo-
cal antibiotic treatment (chloramphenicol four times
a day). Topical steroids were withheld for 48 h. At
1 week the graft was clear and had re-epithelialized.
Long term prophylactic acyclovir 400mg twice a day
was commenced but 6 months later the patient devel-
oped a geographic corneal ulcer involving the graft-
host interface (Fig. 2) with keratic precipitates and
corneal oedema (central corneal thickness 710 μm).
The patient was treated with acyclovir 400mg and
topical aciclovir both five times a day for 2 weeks with
resolution of the ulcer and residual scarring. Although
the patient had HSV IgG serum antibodies, evidence
of HSV-1 DNA was not detected in the first donor
Fig. 2 Geographic corneal ulcer involving thegraft-host inter-
face
20 Management of HSV in a donor cornea K
case report
cornea or following sampling of the corneal ulcer via
PCR and culture methods.
Discussion
The potential transmission of HSV-1 from donor to
host has been recognized by clinical and laboratory
studies [12–14]. Viral particles have been found in
keratocytes and endothelial cells [15] of corneal grafts
with postoperative keratitis. HSV-1 is known to in-
duce endothelial cell necrosis during organ culture,
consistent with reports of postoperative keratitis [5,
16]. A rate of 1.2 per 1000 person-years has been
reported for newly acquired herpetic keratitis in the
early postoperative period [12]. Borderie et al. re-
ported that HSV-1 was responsible for 3 out of 4 pri-
mary graft failures among 586 consecutive grafts per-
formed [17]. Evidence of HSV-1 has been found in
10% of patients with diseased corneas with no history
of HSK undergoing corneal transplantation [16] and
also in cell pellets obtained from donor cornea cul-
ture medium in (%) (3 out of 80) donor corneas [18,
19]. Currently, however, screening assays are not un-
dertaken by eye banks to identify HSV-1 in the donor
cornea or medium during storage.
We describe a case of clinically suspected HSK in
the donor cornea and subsequently in the recipient.
Biswas et al. [20] described the development of pri-
mary graft failure and ulcerative keratitis in two pa-
tients, respectively [20]. Similar to our patient, they
suggested transmission of HSV-1 through organ-cul-
tured corneal graft in two patients in spite of negative
results of PCR performed on both recipient corneas,
based on the presence of endothelial cell necrosis in
the fellow donor cornea in one of the cases. In the pre-
sented case HSV-1 originating from the host cannot be
ruled out as the source of the described viral kerati-
tis, but is deemed highly unlikely given the absence of
previous herpetic disease. Although we were not able
to isolate HSV-1 either from the donor or host, the
clinical appearances were typical in both the donor
and host. Intraoperative and perioperative antiviral
treatment may have prevented potential intraocular
spread to the posterior segment as described by Ather-
ton and Streilein [10, 11] following anterior chamber
inoculation and subsequent disease of the central ner-
vous system in a similar mechanism to oronasal and
vomeronasal spread [21–23]. This case highlights the
issue of being able to adequately examine the donor
corneoscleral disc prior to use. Adequate biomicro-
scopic visualization of the donor cornea is not possi-
ble in the storage transport containers currently used
for organ cultured corneas. This problem could be
addressed by redesigning the transport chamber used
for organ cultured corneas, or the use of hypother-
mic transport containers, which allow assessment of
donor tissue by slit lamp biomicroscopy or the oper-
ating microscope before use [24].
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